{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T03:02:28Z","timestamp":1740106948890,"version":"3.37.3"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,11,17]],"date-time":"2020-11-17T00:00:00Z","timestamp":1605571200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,11,17]],"date-time":"2020-11-17T00:00:00Z","timestamp":1605571200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1007\/s00277-020-04309-7","type":"journal-article","created":{"date-parts":[[2020,11,17]],"date-time":"2020-11-17T23:02:57Z","timestamp":1605654177000},"page":"189-196","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Busulfan, etoposide, cytarabine, and melphalan as a high-dose regimen for autologous stem cell transplantation in peripheral T-cell lymphomas"],"prefix":"10.1007","volume":"100","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6014-7977","authenticated-orcid":false,"given":"Jae-Cheol","family":"Jo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin-Seok","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Je-Hwan","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jung-Hee","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seong Nam","family":"Im","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sang-Min","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sung-Soo","family":"Yoon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"In-Ho","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seong Hwa","family":"Bae","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoo Jin","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yunsuk","family":"Choi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Won-Sik","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,11,17]]},"reference":[{"issue":"23","key":"4309_CR1","doi-asserted-by":"publisher","first-page":"1540","DOI":"10.1056\/nejm199512073332305","volume":"333","author":"T Philip","year":"1995","unstructured":"Philip T, Guglielmi C, Hagenbeek A, Somers R, Van der Lelie H, Bron D, Sonneveld P, Gisselbrecht C, Cahn JY, Harousseau JL et al (1995) Autologous bone marrow transplantation as compared with salvage chemotherapy in relapses of chemotherapy-sensitive non-Hodgkin's lymphoma. N Engl J Med 333(23):1540\u20131545. https:\/\/doi.org\/10.1056\/nejm199512073332305","journal-title":"N Engl J Med"},{"issue":"13","key":"4309_CR2","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1056\/NEJMoa031770","volume":"350","author":"N Milpied","year":"2004","unstructured":"Milpied N, Deconinck E, Gaillard F, Delwail V, Foussard C, Berthou C, Gressin R, Lucas V, Colombat P, Harousseau JL (2004) Initial treatment of aggressive lymphoma with high-dose chemotherapy and autologous stem-cell support. N Engl J Med 350(13):1287\u20131295. https:\/\/doi.org\/10.1056\/NEJMoa031770","journal-title":"N Engl J Med"},{"issue":"11","key":"4309_CR3","doi-asserted-by":"publisher","first-page":"2499","DOI":"10.1080\/10428194.2016.1185785","volume":"57","author":"A Isidori","year":"2016","unstructured":"Isidori A, Christofides A, Visani G (2016) Novel regimens prior to autologous stem cell transplantation for the management of adults with relapsed\/refractory non-Hodgkin lymphoma and Hodgkin lymphoma: alternatives to BEAM conditioning. Leuk Lymphoma 57(11):2499\u20132509. https:\/\/doi.org\/10.1080\/10428194.2016.1185785","journal-title":"Leuk Lymphoma"},{"issue":"3","key":"4309_CR4","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1007\/s11899-017-0382-1","volume":"12","author":"U Zahid","year":"2017","unstructured":"Zahid U, Akbar F, Amaraneni A, Husnain M, Chan O, Riaz IB, McBride A, Iftikhar A, Anwer F (2017) A review of autologous stem cell transplantation in lymphoma. Curr Hematol Malig Rep 12(3):217\u2013226. https:\/\/doi.org\/10.1007\/s11899-017-0382-1","journal-title":"Curr Hematol Malig Rep"},{"issue":"1","key":"4309_CR5","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1007\/s00277-007-0360-0","volume":"87","author":"JC Jo","year":"2008","unstructured":"Jo JC, Kang BW, Jang G, Sym SJ, Lee SS, Koo JE, Kim JW, Kim S, Huh J, Suh C (2008) BEAC or BEAM high-dose chemotherapy followed by autologous stem cell transplantation in non-Hodgkin's lymphoma patients: comparative analysis of efficacy and toxicity. Ann Hematol 87(1):43\u201348. https:\/\/doi.org\/10.1007\/s00277-007-0360-0","journal-title":"Ann Hematol"},{"issue":"2","key":"4309_CR6","first-page":"133","volume":"12","author":"BR Avalos","year":"1993","unstructured":"Avalos BR, Klein JL, Kapoor N, Tutschka PJ, Klein JP, Copelan EA (1993) Preparation for marrow transplantation in Hodgkin's and non-Hodgkin's lymphoma using Bu\/CY. Bone Marrow Transplant 12(2):133\u2013138","journal-title":"Bone Marrow Transplant"},{"issue":"2","key":"4309_CR7","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.leukres.2010.07.016","volume":"35","author":"JE Kim","year":"2011","unstructured":"Kim JE, Lee DH, Yoo C, Kim S, Kim SW, Lee JS, Park CJ, Huh J, Suh C (2011) BEAM or BuCyE high-dose chemotherapy followed by autologous stem cell transplantation in non-Hodgkin's lymphoma patients: a single center comparative analysis of efficacy and toxicity. Leuk Res 35(2):183\u2013187. https:\/\/doi.org\/10.1016\/j.leukres.2010.07.016","journal-title":"Leuk Res"},{"issue":"2","key":"4309_CR8","doi-asserted-by":"publisher","first-page":"119","DOI":"10.5045\/kjh.2012.47.2.119","volume":"47","author":"JC Jo","year":"2012","unstructured":"Jo JC, Yoon DH, Kim S, Park JS, Park CS, Huh J, Lee SW, Ryu JS, Suh C (2012) Yttrium-90 ibritumomab tiuxetan plus busulfan, cyclophosphamide, and etoposide (BuCyE) versus BuCyE alone as a conditioning regimen for non-Hodgkin lymphoma. Korean J Hematol 47(2):119\u2013125. https:\/\/doi.org\/10.5045\/kjh.2012.47.2.119","journal-title":"Korean J Hematol"},{"key":"4309_CR9","doi-asserted-by":"publisher","first-page":"1466","DOI":"10.1038\/s41409-020-0908-3","volume":"55","author":"JC Jo","year":"2020","unstructured":"Jo JC, Kim JS, Lee JH, Lee JH, Lim SN, Lee SM, Yoon SS, Kim IH, Bae SH, Lee YJ, Choi Y, Lee WS (2020) Busulfan, etoposide, cytarabine, and melphalan (BuEAM) as a conditioning regimen for autologous stem cell transplantation in patients with non-Hodgkin lymphoma (NHL). Bone Marrow Transplant 55:1466\u20131468. https:\/\/doi.org\/10.1038\/s41409-020-0908-3","journal-title":"Bone Marrow Transplant"},{"issue":"25","key":"4309_CR10","doi-asserted-by":"publisher","first-page":"4124","DOI":"10.1200\/jco.2008.16.4558","volume":"26","author":"J Vose","year":"2008","unstructured":"Vose J, Armitage J, Weisenburger D (2008) International peripheral T-cell and natural killer\/T-cell lymphoma study: pathology findings and clinical outcomes. J Clin Oncol 26(25):4124\u20134130. https:\/\/doi.org\/10.1200\/jco.2008.16.4558","journal-title":"J Clin Oncol"},{"issue":"5","key":"4309_CR11","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1200\/jco.2006.09.2403","volume":"25","author":"BD Cheson","year":"2007","unstructured":"Cheson BD, Pfistner B, Juweid ME, Gascoyne RD, Specht L, Horning SJ, Coiffier B, Fisher RI, Hagenbeek A, Zucca E, Rosen ST, Stroobants S, Lister TA, Hoppe RT, Dreyling M, Tobinai K, Vose JM, Connors JM, Federico M, Diehl V (2007) Revised response criteria for malignant lymphoma. J Clin Oncol 25(5):579\u2013586. https:\/\/doi.org\/10.1200\/jco.2006.09.2403","journal-title":"J Clin Oncol"},{"issue":"9","key":"4309_CR12","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.1038\/sj.leu.2404306","volume":"20","author":"P Corradini","year":"2006","unstructured":"Corradini P, Tarella C, Zallio F, Dodero A, Zanni M, Valagussa P, Gianni AM, Rambaldi A, Barbui T, Cortelazzo S (2006) Long-term follow-up of patients with peripheral T-cell lymphomas treated up-front with high-dose chemotherapy followed by autologous stem cell transplantation. Leukemia 20(9):1533\u20131538. https:\/\/doi.org\/10.1038\/sj.leu.2404306","journal-title":"Leukemia"},{"issue":"4","key":"4309_CR13","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1093\/annonc\/mdl466","volume":"18","author":"J Rodr\u00edguez","year":"2007","unstructured":"Rodr\u00edguez J, Conde E, Guti\u00e9rrez A, Arranz R, Le\u00f3n \u00c1, Mar\u00edn J, Bendandi M, Albo C, Caballero MD (2007) The results of consolidation with autologous stem-cell transplantation in patients with peripheral T-cell lymphoma (PTCL) in first complete remission: the Spanish Lymphoma and Autologous Transplantation Group experience. Ann Oncol 18(4):652\u2013657. https:\/\/doi.org\/10.1093\/annonc\/mdl466","journal-title":"Ann Oncol"},{"issue":"10","key":"4309_CR14","doi-asserted-by":"publisher","first-page":"2595","DOI":"10.1007\/s00432-019-02999-9","volume":"145","author":"M Roerden","year":"2019","unstructured":"Roerden M, Walz JS, M\u00fcller MR, S\u00f6kler M, Federmann B, Kanz L, Bethge W, Vogel W (2019) The role of autologous stem cell transplantation in peripheral T cell lymphoma: a long-term follow-up single-center experience. J Cancer Res Clin Oncol 145(10):2595\u20132604. https:\/\/doi.org\/10.1007\/s00432-019-02999-9","journal-title":"J Cancer Res Clin Oncol"},{"issue":"25","key":"4309_CR15","doi-asserted-by":"publisher","first-page":"3093","DOI":"10.1200\/jco.2011.40.2719","volume":"30","author":"F d'Amore","year":"2012","unstructured":"d'Amore F, Relander T, Lauritzsen GF, Jantunen E, Hagberg H, Anderson H, Holte H, Osterborg A, Merup M, Brown P, Kuittinen O, Erlanson M, Ostenstad B, Fagerli UM, Gadeberg OV, Sundstrom C, Delabie J, Ralfkiaer E, Vornanen M, Toldbod HE (2012) Up-front autologous stem-cell transplantation in peripheral T-cell lymphoma: NLG-T-01. J Clin Oncol 30(25):3093\u20133099. https:\/\/doi.org\/10.1200\/jco.2011.40.2719","journal-title":"J Clin Oncol"},{"issue":"2","key":"4309_CR16","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1038\/bmt.2009.165","volume":"45","author":"A Numata","year":"2010","unstructured":"Numata A, Miyamoto T, Ohno Y, Kamimura T, Kamezaki K, Tanimoto T, Takase K, Henzan H, Kato K, Takenaka K, Fukuda T, Harada N, Nagafuji K, Teshima T, Akashi K, Harada M, Eto T (2010) Long-term outcomes of autologous PBSCT for peripheral T-cell lymphoma: retrospective analysis of the experience of the Fukuoka BMT group. Bone Marrow Transplant 45(2):311\u2013316. https:\/\/doi.org\/10.1038\/bmt.2009.165","journal-title":"Bone Marrow Transplant"},{"issue":"1","key":"4309_CR17","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1200\/jco.2008.17.4870","volume":"27","author":"P Reimer","year":"2009","unstructured":"Reimer P, R\u00fcdiger T, Geissinger E, Weissinger F, Nerl C, Schmitz N, Engert A, Einsele H, M\u00fcller-Hermelink HK, Wilhelm M (2009) Autologous stem-cell transplantation as first-line therapy in peripheral T-cell lymphomas: results of a prospective multicenter study. J Clin Oncol 27(1):106\u2013113. https:\/\/doi.org\/10.1200\/jco.2008.17.4870","journal-title":"J Clin Oncol"},{"issue":"6","key":"4309_CR18","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1007\/s00277-013-1685-5","volume":"92","author":"JS Ahn","year":"2013","unstructured":"Ahn JS, Yang DH, Jung SH, Chae YS, Sohn SK, Yhim HY, Kwak JY, Lee SR, Kim YK, Kim HJ, Lee JJ (2013) Autologous stem cell transplantation with busulfan, cyclophosphamide, and etoposide as an intensifying frontline treatment in patients with peripheral T cell lymphomas: a multicenter retrospective trial. Ann Hematol 92(6):789\u2013797. https:\/\/doi.org\/10.1007\/s00277-013-1685-5","journal-title":"Ann Hematol"},{"issue":"12","key":"4309_CR19","doi-asserted-by":"publisher","first-page":"3312","DOI":"10.1182\/blood.V78.12.3312.3312","volume":"78","author":"AM Yeager","year":"1991","unstructured":"Yeager AM, Shinn C, Pardoll DM (1991) Lymphoid reconstitution after transplantation of congenic hematopoietic cells in busulfan-treated mice. Blood 78(12):3312\u20133316","journal-title":"Blood"},{"issue":"4","key":"4309_CR20","first-page":"293","volume":"9","author":"AJ Fishleder","year":"1992","unstructured":"Fishleder AJ, Bolwell B, Lichtin AE (1992) Incidence of mixed chimerism using busulfan\/cyclophosphamide containing regimens in allogeneic bone marrow transplantation. Bone Marrow Transplant 9(4):293\u2013297","journal-title":"Bone Marrow Transplant"},{"issue":"5","key":"4309_CR21","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1093\/annonc\/mdn022","volume":"19","author":"S Mercadal","year":"2008","unstructured":"Mercadal S, Briones J, Xicoy B, Pedro C, Escoda L, Estany C, Cam\u00f3s M, Colomo L, Espinosa I, Mart\u00ednez S, Ribera JM, Martino R, Guti\u00e9rrez-Garc\u00eda G, Montserrat E, L\u00f3pez-Guillermo A (2008) Intensive chemotherapy (high-dose CHOP\/ESHAP regimen) followed by autologous stem-cell transplantation in previously untreated patients with peripheral T-cell lymphoma. Ann Oncol 19(5):958\u2013963. https:\/\/doi.org\/10.1093\/annonc\/mdn022","journal-title":"Ann Oncol"},{"issue":"10","key":"4309_CR22","doi-asserted-by":"publisher","first-page":"1504","DOI":"10.1093\/annonc\/mdh391","volume":"15","author":"J Rodriguez","year":"2004","unstructured":"Rodriguez J, Caballero MD, Gutierrez A, Solano C, Arranz R, Lahuerta JJ, Sierra J, Gandarillas M, Perez-Simon JA, Zuazu J, Lopez-Guillermo A, Sureda A, Carreras E, Garcia-Larana J, Marin J, Garcia JC, Fernandez De Sevilla A, Rifon J, Varela R, Jarque I, Albo C, Leon A, SanMiguel J, Conde E (2004) Autologous stem-cell transplantation in diffuse large B-cell non-Hodgkin's lymphoma not achieving complete response after induction chemotherapy: the GEL\/TAMO experience. Ann Oncol 15(10):1504\u20131509. https:\/\/doi.org\/10.1093\/annonc\/mdh391","journal-title":"Ann Oncol"},{"issue":"5","key":"4309_CR23","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1038\/sj.bmt.1705752","volume":"40","author":"S Feyler","year":"2007","unstructured":"Feyler S, Prince HM, Pearce R, Towlson K, Nivison-Smith I, Schey S, Gibson J, Patton N, Bradstock K, Marks DI, Cook G (2007) The role of high-dose therapy and stem cell rescue in the management of T-cell malignant lymphomas: a BSBMT and ABMTRR study. Bone Marrow Transplant 40(5):443\u2013450. https:\/\/doi.org\/10.1038\/sj.bmt.1705752","journal-title":"Bone Marrow Transplant"},{"issue":"3","key":"4309_CR24","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1038\/sj.bmt.1702154","volume":"25","author":"EP Alessandrino","year":"2000","unstructured":"Alessandrino EP, Bernasconi P, Colombo A, Caldera D, Martinelli G, Vitulo P, Malcovati L, Nascimbene C, Varettoni M, Volpini E, Klersy C, Bernasconi C (2000) Pulmonary toxicity following carmustine-based preparative regimens and autologous peripheral blood progenitor cell transplantation in hematological malignancies. Bone Marrow Transplant 25(3):309\u2013313. https:\/\/doi.org\/10.1038\/sj.bmt.1702154","journal-title":"Bone Marrow Transplant"},{"issue":"10","key":"4309_CR25","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1038\/sj.bmt.1702664","volume":"26","author":"MS Akasheh","year":"2000","unstructured":"Akasheh MS, Freytes CO, Vesole DH (2000) Melphalan-associated pulmonary toxicity following high-dose therapy with autologous hematopoietic stem cell transplantation. Bone Marrow Transplant 26(10):1107\u20131109. https:\/\/doi.org\/10.1038\/sj.bmt.1702664","journal-title":"Bone Marrow Transplant"},{"issue":"2","key":"4309_CR26","doi-asserted-by":"publisher","first-page":"159","DOI":"10.2147\/tcrm.2006.2.2.159","volume":"2","author":"D Lionel","year":"2006","unstructured":"Lionel D, Christophe L, Marc A, Jean-Luc C (2006) Oral mucositis induced by anticancer treatments: physiopathology and treatments. Ther Clin Risk Manag 2(2):159\u2013168. https:\/\/doi.org\/10.2147\/tcrm.2006.2.2.159","journal-title":"Ther Clin Risk Manag"},{"issue":"7","key":"4309_CR27","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1002\/ajh.24372","volume":"91","author":"C Yam","year":"2016","unstructured":"Yam C, Landsburg DJ, Nead KT, Lin X, Mato AR, Svoboda J, Loren AW, Frey NV, Stadtmauer EA, Porter DL, Schuster SJ, Nasta SD (2016) Autologous stem cell transplantation in first complete remission may not extend progression-free survival in patients with peripheral T cell lymphomas. Am J Hematol 91(7):672\u2013676. https:\/\/doi.org\/10.1002\/ajh.24372","journal-title":"Am J Hematol"},{"issue":"3","key":"4309_CR28","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1093\/annonc\/mdx787","volume":"29","author":"G Fossard","year":"2018","unstructured":"Fossard G, Broussais F, Coelho I, Bailly S, Nicolas-Virelizier E, Toussaint E, Lancesseur C, Le Bras F, Willems E, Tchernonog E, Chalopin T, Delarue R, Gressin R, Chauchet A, Gyan E, Cartron G, Bonnet C, Haioun C, Damaj G, Gaulard P, Fornecker L, Ghesqui\u00e8res H, Tournilhac O, da Silva MG, Bouabdallah R, Salles G, Bachy E (2018) Role of up-front autologous stem-cell transplantation in peripheral T-cell lymphoma for patients in response after induction: an analysis of patients from LYSA centers. Ann Oncol 29(3):715\u2013723. https:\/\/doi.org\/10.1093\/annonc\/mdx787","journal-title":"Ann Oncol"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-020-04309-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00277-020-04309-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-020-04309-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,29]],"date-time":"2022-07-29T01:34:53Z","timestamp":1659058493000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00277-020-04309-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,17]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,1]]}},"alternative-id":["4309"],"URL":"https:\/\/doi.org\/10.1007\/s00277-020-04309-7","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"type":"print","value":"0939-5555"},{"type":"electronic","value":"1432-0584"}],"subject":[],"published":{"date-parts":[[2020,11,17]]},"assertion":[{"value":"5 July 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 October 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 November 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}